|
Index of reports
> Cases resulting in life threatening events (3)
> Cases with Platelet Count Decreased (2)
Below is the selection of adverse event reports related to Tagamet (Cimetidine) that includes cases resulting in life threatening events where reactions include platelet count decreased.
Adverse event in 90 year old male receiving Tagamet (Cimetidine)
Reported by a individual with unspecified qualification from Japan on 2007-10-01
Patient: 90 year old male
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, RED Blood Cell Count Decreased, Drug Ineffective, Gamma-Glutamyltransferase Increased, Platelet Count Decreased, Idiopathic Thrombocytopenic Purpura, Blood Immunoglobulin E Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Rifampicin
Administration route: Oral
Indication: Tuberculosis
Start date: 2007-04-26
End date: 2007-08-03
Iscotin / 00030201 /
Administration route: Oral
Indication: Tuberculosis
Start date: 2007-04-26
End date: 2007-08-03
Ebutol / 00022301 /
Administration route: Oral
Indication: Pulmonary Tuberculosis
Start date: 2007-04-26
End date: 2007-08-03
Ebutol / 00022301 /
Administration route: Oral
Indication: Tuberculous Pleurisy
Start date: 2007-04-26
End date: 2007-08-03
Tagamet
Administration route: Oral
Indication: Gastrooesophageal Reflux Prophylaxis
Start date: 2007-04-15
End date: 2007-08-03
Other drugs received by patient: Mucodyne; Mucosolvan; Codiene; Magmitt; Halfdigoxin
Adverse event in 65 year old female receiving Tagamet (Cimetidine)
Reported by a physician from Japan on 2007-06-14
Patient: 65 year old female, weighing 54.0 kg (118.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Gastrointestinal Haemorrhage, Pneumonia, Anaemia, General Physical Health Deterioration, Disease Progression, Glioblastoma, Pneumocystis Jiroveci Pneumonia, Cardiac Failure, Platelet Count Decreased
Adverse event resulted in: death, life threatening event, disablity
Suspect drug(s):
Temodal
Dosage: 75 mg/m2; qd; po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-12-22
End date: 2007-01-29
Valproate Sodium
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-22
End date: 2007-02-05
Tagamet
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-22
End date: 2007-02-05
Betamethasone
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-22
Other drugs received by patient: Nasea-OD; Dogmatyl; Maalox Fast Blocker; Maglax; Pursennid; Levofloxacin; Aleviatin; Zantac; Takepron OD; Thyradin-S; Pariet
|
